Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Reckitt
Reckitt
Activities:
Body Care
Skin Care
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Kemtile appointed as a single-source supplier by Reckitt
Kemtile, a division of Stonhard, has been appointed as a single-source supplier to design and install a new flooring solution for production area corridors at Reckitt (formerly Reckitt Benckiser) in Nottingham, UK
Design & Build
M+W Group starts building RB’s new Centre for Scientific Excellence in UK
Groundwork has already begun on the R&D Centre in Dansom Lane, Hull, that will provide a GMP development facility and pilot plant
Regulatory
Australian Federal Court finds Reckitt Benckiser made misleading claims about content of its painkillers
Orders Nurofen Specific Pain product range to be removed from retail shelves
Finance
Reckitt Benckiser to spin off its pharmaceuticals business
Will be renamed Indivior and continue to concentrate on treatments for opioid addiction
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Competition Law is catching pharma companies out
With major multinationals paying a high price for illegal and corrupt market activities, Paul Henty and Rory Ashmore, of legal firm Speechly Bircham, review the underlying causes and the risks
Media
Reckitt Benckiser licenses Atrigel Technology from QTL
<p>Reckitt Benckiser Pharmaceuticals Inc, based in Richmond, VA, has set up a licensing agreement with QLT USA, for Atrigel sustained-release drug delivery technology.</p>
Subscribe now